Please assess the completion status of the following clinical trial:

Trial Title: Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria: 1) female aged 15 through 21 presenting for contraception; 2) willing to use the NuvaRing as their contraceptive method; 3) English-speaking; 4) up to date on routine health maintenance screening (pap smear within 3 years of initiation of sexual intercourse and Gonorrhea/ Chlamydia testing yearly or with each new partner); and 5) able to read and understand the consent form.~Exclusion Criteria: 1) are pregnant; 2) have a contraindication to hormonal contraception; 3) are unwilling to use NuvaRing as their contraceptive method; 4) are currently using any hormonal contraceptive or have used one within past 2 months; 5) have used emergency contraception in the past 7 days; 6) have had unprotected intercourse in the past 10 days; 7) have untreated Gonorrhea or Chlamydia; or 8) are unable to give informed consent because of psychiatric or cognitive problems.

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 21 Years
- Healthy Volunteers: t

Study Arms:
- Quick start (Type: EXPERIMENTAL): Start contraceptive method (NuvaRing) day of enrollment
- Traditional start (Type: ACTIVE_COMPARATOR): Start contraceptive method (NuvaRing) after next menses (per package insert)

Based on this trial design, predict the completion outcome and termination type (if applicable).